Duality Advisers, LP Coherus Bio Sciences, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$10.92 - $16.41 $595,019 - $894,164	-54,489 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$15.81 - $18.99 $861,471 - $1.03 Million	54,489 New	54,489 $870,000
Q2 2021 Aug 09, 2021	SELL	$12.95 - $15.41 $635,314 - $755,999	-49,059 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $628,019 - $931,577	-43,552 Reduced 47.03%	49,059 $717,000
Q4 2020 Feb 09, 2021	BUY	$16.56 - $18.94 $685,269 - $783,756	41,381 Added 80.77%	92,611 $1.61 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $891,914 - $1.02 Million	51,230 New	51,230 $940,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.